PMID- 18453060
OWN - NLM
STAT- MEDLINE
DCOM- 20080520
LR  - 20190816
IS  - 0869-2084 (Print)
IS  - 0869-2084 (Linking)
IP  - 3
DP  - 2008 Mar
TI  - [Significance of the determination of B2-glycoprotein-1 antibodies in recognizing 
      the thrombogenicity in antiphospholipid syndrome].
PG  - 38-9
AB  - According to the recent data, the determination of the higher titer of antibodies 
      to beta2-glycoprotein-I (beta2-GP-I) that is included in a complex compound with 
      negative phospholipid membranes determinates the thrombogenicity in 
      antiphospholipid syndrome (APS). To specify this regularity, the authors examined 
      86 patients with primary APS and 20 patients with venous and arterial thrombosis 
      without APS. With increased beta2-GP-I antibody levels, the incidence of 
      thrombotic events was established to w significantly higher than in APS without 
      the increased titer of beta2-GP-I antibodies. In primary APS-associated 
      persistent miscarriage, the increased titer of beta2-GP-I is much more 
      infrequently encountered.
FAU - Serdiuk, G V
AU  - Serdiuk GV
FAU - Selivanov, E V
AU  - Selivanov EV
FAU - Barkagan, Z S
AU  - Barkagan ZS
LA  - rus
PT  - English Abstract
PT  - Journal Article
PL  - Russia (Federation)
TA  - Klin Lab Diagn
JT  - Klinicheskaia laboratornaia diagnostika
JID - 9432021
RN  - 0 (Autoantibodies)
RN  - 0 (beta 2-Glycoprotein I)
SB  - IM
MH  - Abortion, Habitual/*blood/immunology
MH  - Adult
MH  - Antiphospholipid Syndrome/*blood/immunology
MH  - Autoantibodies/*blood/immunology
MH  - Female
MH  - Humans
MH  - Male
MH  - Pregnancy
MH  - Pregnancy Complications, Hematologic/*blood/immunology
MH  - Thrombosis/*blood/immunology
MH  - *beta 2-Glycoprotein I/immunology
EDAT- 2008/05/03 09:00
MHDA- 2008/05/21 09:00
CRDT- 2008/05/03 09:00
PHST- 2008/05/03 09:00 [pubmed]
PHST- 2008/05/21 09:00 [medline]
PHST- 2008/05/03 09:00 [entrez]
PST - ppublish
SO  - Klin Lab Diagn. 2008 Mar;(3):38-9.